Prospective Phase II Multicenter Study of Conditioning with Treosulfan, Fludarabine and Low-Dose (2 Gy) Total Body Irradiation Followed by Hematopoietic Cell Transplantation From Related or Unrelated Donors for Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Boglarka Gyurkocza(Cornell University), H. Joachim Deeg(Fred Hutch Cancer Center), Colleen Delaney(Seattle Children's Hospital), Eneida R. Nemecek(Oregon Health & Science University), Jonathan A. Gutman(University of Colorado Denver), Joachim Baumgart(Medac (Germany)), Frederick R. Appelbaum(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Merav Bar(Fred Hutch Cancer Center), Barry E. Storer(City Of Hope National Medical Center), Eileen Sickle(Fred Hutch Cancer Center)
Cited by 1
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k